Monday, March 4, 2013

P&G Post Analysis

After careful consideration of the options presented by the very helpful consultants, I stand by their recommendation to implement a web-enabled EDC. However, the obstacles such as learning curves, IT infrastructure, and security should be carefully addressed during the role-out of a new system. I do not believe these outweigh the benefits of a significant decrease in testing time and therefore an increase in total earnings of those drugs that make it to the market.

I recommend a follow-up pilot program to that initially performed with the same site coordinators, investigators, and investigator sites to gauge the long term adaptability beyond the initial setup and implementation. I believe this will provide the greatest measurement of accuracy to the return on this investment.

No comments:

Post a Comment